Ausperbio
1 known investors
AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV). It uses a proprietary Med-Oligo ASO platform and targeted delivery technologies to address viral infections, metabolic, genetic, and immune diseases.
Founders & leadership
GC
Guofeng ChenginCo-Founder & CEO
Investors · 1
Frequently asked questions
- What does Ausperbio do?
- AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV). It uses a proprietary Med-Oligo ASO platform and targeted delivery technologies to address viral infections, metabolic, genetic, and immune diseases.
- Who founded Ausperbio?
- Ausperbio was founded by Guofeng Cheng.
- Who are Ausperbio's investors?
- Ausperbio's investors include Qiming Venture Partners.